Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma.

Kidney cancer (Clifton, Va.) Pub Date : 2023-03-23 eCollection Date: 2023-01-01 DOI:10.3233/KCA-229030
Akanksha Sharma, Roy Elias, Alana Christie, Noelle S Williams, Ivan Pedrosa, Georg A Bjarnason, James Brugarolas
{"title":"Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma.","authors":"Akanksha Sharma, Roy Elias, Alana Christie, Noelle S Williams, Ivan Pedrosa, Georg A Bjarnason, James Brugarolas","doi":"10.3233/KCA-229030","DOIUrl":null,"url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3233/KCA-210117.].</p>","PeriodicalId":74039,"journal":{"name":"Kidney cancer (Clifton, Va.)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/7c/kca-7-kca229030.PMC10041931.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney cancer (Clifton, Va.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/KCA-229030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

[This corrects the article DOI: 10.3233/KCA-210117.].

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
勘误:在转移性肾细胞癌中增加非常规卡博赞替尼剂量可延长疾病控制时间
[此处更正了文章 DOI:10.3233/KCA-210117]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations. Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic Review. Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma. A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer. Evaluating the Optimal Duration of Immunotherapy in Kidney Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1